Toxicogenomics in Drug Discovery and Development: Mechanistic Analysis of Compound/Class-Dependent Effects Using the Drugmatrix^® Database

• Service RF : Surviving the blockbuster syndrome.Science303(5665) , 1796–1799 (2004).
   PubMed Web of Science ®Google Scholar
• Kola I , LandisJ: Can the pharmaceutical industry reduce attrition rates?Nat. Rev. Drug Discov.3(8) , 711–715 (2004).
   PubMed Web of Science ®Google Scholar
• DiMasi JA , HansenRW, GrabowskiHG: The price of innovation: new estimates of drug development costs.J. Health Econ.22(2) , 151–185 (2003).
   PubMed Web of Science ®Google Scholar
• Ulrich R , FriendSH: Toxicogenomics and drug discovery: will new technologies help us produce better drugs?Nat. Rev. Drug Discov.1(1) , 84–88 (2002).
   PubMed Web of Science ®Google Scholar
• Waters MD , FostelJM: Toxicogenomics and systems toxicology: aims and prospects.Nat. Rev. Genet.5(12) , 936–948 (2004).
   PubMed Web of Science ®Google Scholar
• Nuwaysir EF , BittnerM, TrentJ, BarrettJC, AfshariCA: Microarrays and toxicology: the advent of toxicogenomics.Mol. Carcinog.24(3) , 153–9. (1999).
   PubMed Web of Science ®Google Scholar
• Baker VA , HarriesHM, WaringJF et al.: Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arrays. Environ. Health Perspect.112(4) , 428–438 (2004).
   PubMed Web of Science ®Google Scholar
• Hughes TR , MartonMJ, JonesAR et al.: Functional discovery via a compendium of expression profiles. Cell102(1) , 109–126 (2000).
   PubMed Web of Science ®Google Scholar
• Ganter B , TugendreichS, PearsonCI et al.: Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J. Biotechnol.119(3) , 219–244 (2005).
   PubMed Web of Science ®Google Scholar
• Wetmore BA , MerrickBA: Toxicoproteomics: proteomics applied to toxicology and pathology.Toxicol. Pathol.32(6) , 619–642 (2004).
   PubMed Web of Science ®Google Scholar
• Shioda T : Application of DNA microarray to toxicological research.J. Environ. Pathol. Toxicol. Oncol.23(1) , 13–31 (2004).
   PubMed Web of Science ®Google Scholar
• Powell CL , KosykO, RossPK et al.: Phenotypic anchoring of acetaminophen-induced oxidative stress with gene expression profiles in rat liver. Toxicol. Sci.93(1) , 213–222 (2006).
   PubMed Web of Science ®Google Scholar
• Moggs JG , TinwellH, SpurwayT et al.: Phenotypic anchoring of gene expression changes during estrogen-induced uterine growth. Environ. Health Perspect.112(16) , 1589–1606 (2004).
   PubMed Web of Science ®Google Scholar
• Heinloth AN , IrwinRD, BoormanGA et al.: Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol. Sci.80(1) , 193–202 (2004).
   PubMed Web of Science ®Google Scholar
• Fielden MR , EynonBP, NatsoulisG, JarnaginK, BanasD, KolajaKL: A gene expression signature that predicts the future onset of drug-induced renal tubular toxicity.Toxicol. Pathol.33(6) , 675–683 (2005).
   PubMed Web of Science ®Google Scholar
• Thukral SK , NordonePJ, HuR et al.: Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers. Toxicol. Pathol.33(3) , 343–355 (2005).
   PubMed Web of Science ®Google Scholar
• Peterson RL , CasciottiL, BlockL et al.: Mechanistic toxicogenomic analysis of WAY-144122 administration in Sprague-Dawley rats. Toxicol. Appl. Pharmacol.196(1) , 80–94 (2004).
   PubMed Web of Science ®Google Scholar
• Ruepp S , BoessF, SuterL, de Vera MC, Steiner G, Steele T et al.: Assessment of hepatotoxic liabilities by transcript profiling. Toxicol. Appl. Pharmacol.207(Suppl. 2) , 161–170 (2005).
   PubMedGoogle Scholar
• Tugendreich S , PearsonCI, SagartzJ, JarnaginK, KolajaK: NSAID-induced acute phase response is due to increased intestinal permeability and characterized by early and consistent alterations in hepatic gene expression.Toxicol. Pathol.34(2) , 168–179 (2006).
   PubMed Web of Science ®Google Scholar
• Waring JF , LiguoriMJ, LuyendykJP et al.: Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophils. J. Pharmacol. Exp. Ther.316(3) , 1080–1087 (2006).
   PubMed Web of Science ®Google Scholar
• Elrick MM , KramerJA, AldenCL et al.: Differential display in rat livers treated for 13 weeks with phenobarbital implicates a role for metabolic and oxidative stress in nongenotoxic carcinogenicity. Toxicol. Pathol.33(1) , 118–126 (2005).
   PubMed Web of Science ®Google Scholar
• Liguori MJ , AndersonMG, BukofzerS et al.: Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin. Hepatology41(1) , 177–186 (2005).
   PubMed Web of Science ®Google Scholar
• Sawada H , TakamiK, AsahiS: A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.Toxicol. Sci.83(2) , 282–292 (2005).
   PubMed Web of Science ®Google Scholar
• Burczynski ME , McMillianM, Ciervo Jet al.: Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol. Sci.58(2) , 399–415. (2000).
   PubMed Web of Science ®Google Scholar
• Debouck C , GoodfellowPN: DNA microarrays in drug discovery and development.Nat. Genet.21 , 48–50 (1999).
   PubMed Web of Science ®Google Scholar
• Hamadeh HK , AminRP, PaulesRS, Afshari CA: An overview of toxicogenomics. Curr. Issues Mol. Biol.4(2) , 45–56 (2002).
   PubMedGoogle Scholar
• Harris K , LamsonRE, NelsonB et al.: Role of scaffolds in MAP kinase pathway specificity revealed by custom design of pathway-dedicated signaling proteins. Curr. Biol.11(23) , 1815–1824. (2001).
   PubMed Web of Science ®Google Scholar
• Waring J .F., Ciurlionis R, Jolly RA, Heindel M, Ulrich RG: Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol. Lett.120(1–3) , 359–368 (2001).
   PubMed Web of Science ®Google Scholar
• Waring JF , JollyRA, CiurlionisR et al.: Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol. Appl. Pharmacol.175(1) , 28–42 (2001).
   PubMed Web of Science ®Google Scholar
• Bailey WJ , UlrichR: Molecular profiling approaches for identifying novel biomarkers.Expert. Opin. Drug Saf..3(2) , 137–151 (2004).
   PubMedGoogle Scholar
• Ellinger-Ziegelbauer H , StuartB, WahleB, BomannW, AhrHJ: Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.Mutat. Res.575(1–2) , 61–84 (2005).
   PubMed Web of Science ®Google Scholar
• Fisher MT , NagarkattiM, NagarkattiPS: Combined screening of thymocytes using apoptosis-specific cDNA array and promoter analysis yields novel gene targets mediating TCDD-induced toxicity.Toxicol. Sci.78(1) , 116–124 (2004).
   PubMed Web of Science ®Google Scholar
• Amin RP , VickersAE, SistareF et al.: Identification of putative gene based markers of renal toxicity. Environ. Health Perspect.112(4) , 465–479 (2004).
   PubMed Web of Science ®Google Scholar
• Heijne WH , SlittAL, van Bladeren PJ et al.: Bromobenzene-induced hepatotoxicity at the transcriptome level. Toxicol. Sci.79(2) , 411–422 (2004).
   PubMed Web of Science ®Google Scholar
• McMillian M , NieA, ParkerJB et al.: Drug-induced oxidative stress in rat liver from a toxicogenomics perspective. Toxicol. Appl. Pharmacol.207(2 Suppl) , 171–178 (2005).
   PubMedGoogle Scholar
• McMillian M , NieAY, ParkerJB et al.: Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver. Biochem. Pharmacol.67(11) , 2141–2165 (2004).
   PubMed Web of Science ®Google Scholar
• Wallace KB , HausnerE, HermanE et al.: Serum troponins as biomarkers of drug-induced cardiac toxicity. Toxicol. Pathol.32(1) , 106–121 (2004).
   PubMed Web of Science ®Google Scholar
• Newton RK , AardemaM, AubrechtJ: The utility of DNA microarrays for characterizing genotoxicity.Environ. Health Perspect.112(4) , 420–422 (2004).
   PubMed Web of Science ®Google Scholar
• Ellinger-Ziegelbauer H , StuartB, WahleB, BomannW, AhrHJ: Characteristic expression profiles induced by genotoxic carcinogens in rat liver.Toxicol. Sci.77(1) , 19–34 (2004).
   PubMed Web of Science ®Google Scholar
• Salter AH : Large-scale databases in toxicogenomics.Pharmacogenomics6(7) , 749–754 (2005).
   PubMed Web of Science ®Google Scholar
• Waters M , BoormanG, BushelP et al.: Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base. EHP Toxicogenomics111(1T) , 15–28 (2003).
   PubMedGoogle Scholar
• Xirasagar S , GustafsonS, MerrickBA et al.: CEBS object model for systems biology data SysBio-OM. Bioinformatics20(13) , 2004–2015 (2004).
   PubMed Web of Science ®Google Scholar
• Tong W , HarrisS, CaoX et al.: Development of public toxicogenomics software for microarray data management and analysis. Mutat. Res.549(1–2) , 241–253 (2004).
   PubMed Web of Science ®Google Scholar
• Brazma A , ParkinsonH, SarkansU et al.: ArrayExpress – a public repository for microarray gene expression data at the EBI. Nucleic Acids Res.31(1) , 68–71 (2003).
   PubMed Web of Science ®Google Scholar
• Mattes WB , PettitSD, SansoneSA, Bushel PR, Waters MD: Database development in toxicogenomics: issues and efforts. Environ. Health Perspect.112(4) , 495–505 (2004).
   PubMed Web of Science ®Google Scholar
• Pennie W , PettitSD, LordPG: Toxicogenomics in risk assessment: an overview of an HESI collaborative research program.Environ. Health Perspect.112(4) , 417–419 (2004).
   PubMed Web of Science ®Google Scholar
• Castle AL , CarverMP, MendrickDL: Toxicogenomics: a new revolution in drug safety.Drug Discov. Today7(13) , 728–736 (2002).
   PubMed Web of Science ®Google Scholar
• Fielden MR , KolajaKL: The state-of-the-art in predictive toxicogenomics.Curr. Opin. Drug Discov. Devel.9(1) , 84–91 (2006).
   PubMedGoogle Scholar
• Chu TM , DengS, WolfingerR, PaulesRS, HamadehHK: Cross-site comparison of gene expression data reveals high similarity.Environ. Health Perspect.112(4) , 449–455 (2004).
   PubMed Web of Science ®Google Scholar
• Boorman GA , BlackshearPE, ParkerJS et al.: Hepatic gene expression changes throughout the day in the Fischer rat: implications for toxicogenomic experiments. Toxicol. Sci.86(1) , 185–193 (2005).
   PubMed Web of Science ®Google Scholar
• Reynolds VL : Applications of emerging technologies in toxicology and safety assessment.Int. J. Toxicol.24(3) , 135–137 (2005).
   PubMed Web of Science ®Google Scholar
• Cheng Y , ChurchGM: Biclustering of expression data.Proc. Int. Conf. Intell. Syst. Mol. Biol.8 , 93–103 (2000).
   PubMedGoogle Scholar
• Sorlie T , PerouCM, TibshiraniR et al.: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA98(19) , 10869–10874 (2001).
   PubMed Web of Science ®Google Scholar
• van Delft JH , van Agen E, van Breda SG, Herwijnen MH, Staal YC, Kleinjans JC: Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling. Mutat. Res.575(1–2) , 17–33 (2005).
   PubMed Web of Science ®Google Scholar
• Brown MP , GrundyWN, LinD et al.: Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc. Natl Acad. Sci. USA97(1) , 262–267 (2000).
   PubMed Web of Science ®Google Scholar
• Raychaudhuri S , StuartJM, AltmanRB: Principal components analysis to summarize microarray experiments: application to sporulation time series.Pac. Symp. Biocomput.455–466 (2000).
   PubMedGoogle Scholar
• Califano A , StolovitzkyG, TuY: Analysis of gene expression microarrays for phenotype classification.Proc. Int. Conf. Intell. Syst. Mol. Biol.8 , 75–85 (2000).
   PubMedGoogle Scholar
• Alizadeh AA , RossDT, PerouCM, van de Rijn M: Towards a novel classification of human malignancies based on gene expression patterns. J. Pathol.195(1) , 41–52 (2001).
   PubMed Web of Science ®Google Scholar
• Furey TS , CristianiniN, DuffyN, BednarskiDW, SchummerM, HausslerD: Support vector machine classification and validation of cancer tissue samples using microarray expression data.Bioinformatics16(10) , 906–914 (2000).
   PubMed Web of Science ®Google Scholar
• Golub TR , SlonimDK, TamayoP et al.: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science286(5439) , 531–537 (1999).
   PubMed Web of Science ®Google Scholar
• Raghavan N , AmaratungaD, NieAY, McMillianM: Class prediction in toxicogenomics.J. Biopharm. Stat.15(2) , 327–341 (2005).
   PubMed Web of Science ®Google Scholar
• Natsoulis G , El Ghaoui L, Lanckriet GRG et al.: Classification of a large microarray data set: algorithm comparison and analysis of drug signatures. Genome Res.15(5) , 724–736 (2005).
   PubMed Web of Science ®Google Scholar
• El Ghaoui L , LanckrietGRG, NatsoulisG: Robust classifiers with interval data. Report UCB/CSD-03–1279, Computer Science Division (EECS), University of California, Berkeley, CA, USA (2003).
   Google Scholar
• Smecuol E , BaiJC, SugaiE et al.: Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut49(5) , 650–655 (2001).
   PubMed Web of Science ®Google Scholar
• Hawkey CJ : Cyclooxygenase inhibition: between the devil and the deep blue sea.Gut50(Suppl 3) , 25–30 (2002).
   PubMed Web of Science ®Google Scholar
• James MW , HawkeyCJ: Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract.Br. Clin. Pharmacol.56(2) , 146–155 (2003).
   PubMed Web of Science ®Google Scholar
• Laine L : The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.Semin. Arthritis Rheum.32(3 Suppl. 1) , 25–32 (2002).
   PubMed Web of Science ®Google Scholar
• Pronai L , HritzI, MolnarB, HerszenyiL, TulassayZ: COX-2-selective inhibitors (COXIBs): gastrointestinal safety.Int. J. Immunopathol. Pharmacol.16(2 Suppl.) , 23–30 (2003).
   PubMed Web of Science ®Google Scholar
• Laporte JR , IbanezL, VidalX, VendrellL, LeoneR: Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents.Drug Saf.27(6) , 411–420 (2004).
   PubMed Web of Science ®Google Scholar
• Micklewright R , LaneS, LinleyW, McQuadeC, ThompsonF, MaskreyN: NSAIDs, gastroprotection and cyclo-oxygenase-II-selective inhibitors.Aliment Pharmacol. Ther.17(3) , 321–332 (2003).
   PubMed Web of Science ®Google Scholar
• Souness JE , AldousD, SargentC: Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors.Immunopharmacology47(2–3) , 127–162 (2000).
   PubMed Web of Science ®Google Scholar
• Dyke HJ , MontanaJG: Update on the therapeutic potential of PDE4 inhibitors.Expert Opin. Investig. Drugs11(1) , 1–13 (2002).
   PubMed Web of Science ®Google Scholar
• Morgan ET : Regulation of cytochromes P450 during inflammation and infection.Drug Metab. Rev.29(4) , 1129–1188 (1997).
   PubMed Web of Science ®Google Scholar
• Renton KW : Alteration of drug biotransformation and elimination during infection and inflammation.Pharmacol. Ther.92(2–3) , 147–163 (2001).
   PubMed Web of Science ®Google Scholar
• Slaviero KA , ClarkeSJ, RivoryLP: Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy.Lancet Oncol.4(4) , 224–232 (2003).
   PubMed Web of Science ®Google Scholar
• Hartmann G , CheungAK, Piquette-Miller M: Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J. Pharmacol. Exp. Ther.303(1) , 273–281 (2002).
   PubMed Web of Science ®Google Scholar
• Hartmann G , KimH, Piquette-MillerM: Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice.Int. Immunopharmacol.1(2) , 189–199 (2001).
   PubMed Web of Science ®Google Scholar
• Goralski KB , HartmannG, Piquette-Miller M, Renton KW: Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br. J. Pharmacol.139(1) , 35–48 (2003).
   PubMed Web of Science ®Google Scholar
• Piquette-Miller M , PakA, KimH, AnariR, ShahzamaniA: Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation.Pharm. Res.15(5) , 706–711 (1998).
   PubMed Web of Science ®Google Scholar
• Tang W , YiC, KalitskyJ, Piquette-Miller M: Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats. Mol. Cell Biol. Res. Commun.4(2) , 90–97 (2000).
   PubMedGoogle Scholar
• Payen L , SparfelL, CourtoisA, VernhetL, GuillouzoA, FardelO: The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds.Cell Biol. Toxicol.18(4) , 221–233 (2002).
   PubMed Web of Science ®Google Scholar
• Warren GW , van Ess PJ, Watson AM, Mattson MP, Blouin RA: Cytochrome P450 and antioxidant activity in interleukin-6 knockout mice after induction of the acute-phase response. J. Interferon Cytokine Res.21(10) , 821–826 (2001).
   PubMed Web of Science ®Google Scholar
• Sukhai M , YongA, KalitskyJ, Piquette-MillerM: Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the MDR1A and MDR1B genes.Mol. Cell Biol. Res. Commun.4(4) , 248–256 (2000).
   PubMedGoogle Scholar
• Lee G , Piquette-MillerM: Influence of IL-6 on MDR, MRP-mediated multidrug resistance in human hepatoma cells.Can. J. Physiol. Pharmacol.79(10) , 876–884 (2001).
   PubMed Web of Science ®Google Scholar
• Morgan ET : Regulation of cytochrome p450 by inflammatory mediators: why and how?Drug Metab. Dispos.29(3) , 207–212 (2001).
   PubMed Web of Science ®Google Scholar
• Ghose R , ZimmermanTL, ThevanantherS, KarpenSJ: Endotoxin leads to rapid subcellular re-localization of hepatic RXRα: A novel mechanism for reduced hepatic gene expression in inflammation.Nucl. Recept.2(1) , 4 (2004).
   PubMedGoogle Scholar
• Synold TW , DussaultI, FormanBM: The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux.Nat. Med.7(5) , 584–590 (2001).
   PubMed Web of Science ®Google Scholar
• Khatsenko OG , GrossSS, RifkindAB, Vane JR: Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl Acad. Sci. USA90(23) , 11147–11151 (1993).
   PubMed Web of Science ®Google Scholar
• Oyekan AO : The suppression by lipopolysaccharide of cytochrome P450-dependent renal vasodilation in the rat is mediated by nitric oxide.Eur. J. Pharmacol.277(2–3) , 123–132 (1995).
   PubMed Web of Science ®Google Scholar
• Wink DA , OsawaY, DarbyshireJF, Jones CR, Eshenaur SC, Nims RW: Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys.300(1) , 115–123 (1993).
   PubMed Web of Science ®Google Scholar
• Stadler J , TrockfeldJ, SchmalixWA et al.: Inhibition of cytochromes P4501A by nitric oxide. Proc. Natl Acad. Sci. USA91(9) , 3559–3563 (1994).
   PubMed Web of Science ®Google Scholar
• Osawa Y , DavilaJC, NakatsukaM, Meyer CA, Darbyshire JF: Inhibition of P450 cytochromes by reactive intermediates. Drug Metab. Rev.27(1–2) , 61–72 (1995).
   PubMed Web of Science ®Google Scholar
• Khatsenko O , KikkawaY: Nitric oxide differentially affects constitutive cytochrome P450 isoforms in rat liver.J. Pharmacol. Exp. Ther.280(3) , 1463–1470 (1997).
   PubMed Web of Science ®Google Scholar
• Vossen C , ErardM: Down-regulation of nuclear receptor DNA-binding activity by nitric oxide – HNF4 as a model system.Med. Sci. Monit.8(10) , RA217–RA220 (2002).
   PubMedGoogle Scholar
• Nikitovic D , HolmgrenA, SpyrouG: Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos.Biochem. Biophys. Res. Commun.242(1) , 109–112 (1998).
   PubMed Web of Science ®Google Scholar
• Kroncke KD , FehselK, SchmidtT et al.: Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9. Biochem. Biophys. Res. Commun.200(2) , 1105–1110 (1994).
   PubMed Web of Science ®Google Scholar
• Day G , BradyL, RyanTP et al.: Characterization of compound-induced heptotoxicity using gene expression profiling in rat primary hepatocytes. Presented at: Society of Toxicology Annual Meeting, March 5–9, San Diego, CA, USA (2006) (Abstract No. 2392).
   Google Scholar
• Gao J , Ann Garulacan L, Storm SM et al.: Identification of in vitro protein biomarkers of idiosyncratic liver toxicity. Toxicol. In Vitro18(4) , 533–541 (2004).
   PubMed Web of Science ®Google Scholar
• O’Brien PJ , ChanK, SilberPM: Human and animal hepatocytes in vitro with extrapolation in vivo.Chem. Biol. Interact.150(1) , 97–114 (2004).
   PubMed Web of Science ®Google Scholar
• Kier LD , NeftR, TangL et al.: Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro. Mutat. Res.549(1–2) , 101–113 (2004).
   PubMed Web of Science ®Google Scholar
• Gunn L , SmithMT: Emerging biomarker technologies.IARC Sci. Publ.157 , 437–450 (2004).
   Google Scholar
• Burczynski ME , DornerAJ: Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies.Pharmacogenomics7(2) , 187–202 (2006).
   PubMed Web of Science ®Google Scholar
• Maas K , ChanS, ParkerJ et al.: Cutting edge: molecular portrait of human autoimmune disease. Immunol.169(1) , 5–9 (2002).
   Web of Science ®Google Scholar
• Aune TM , MaasK, MooreJH, OlsenNJ: Gene expression profiles in human autoimmune disease.Curr. Pharm. Des.9(23) , 1905–1917 (2003).
   PubMed Web of Science ®Google Scholar
• Crow MK , WohlgemuthJ: Microarray analysis of gene expression in lupus.Arthritis Res. Ther.5(6) , 279–287 (2003).
   PubMed Web of Science ®Google Scholar
• Moos PJ , RaetzEA, CarlsonMA et al.: Identification of gene expression profiles that segregate patients with childhood leukemia. Clin. Cancer Res.8(10) , 3118–3130 (2002).
   PubMed Web of Science ®Google Scholar
• Feezor RJ , BakerHV, XiaoW et al.: Genomic and proteomic determinants of outcome in patients undergoing thoracoabdominal aortic aneurysm repair. J. Immunol.172(11) , 7103–7109 (2004).
   PubMed Web of Science ®Google Scholar
• Baranzini SE , MousaviP, RioJ et al.: Transcription-based prediction of response to IFNβ using supervised computational methods. PLoS Biol.3(1) , E2 (2005).
   PubMed Web of Science ®Google Scholar
• Burczynski ME , TwineNC, DukartG et al.: Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma. Clin. Cancer Res.11(3) , 1181–1189 (2005).
   PubMed Web of Science ®Google Scholar
• Pearson C , FujimotoS, JudoM et al.: Blood as a toxicogenomic tissue. Presented at: Society of Toxicology Annual Meeting, March 5–9, San Diego, CA, USA (2006) (Abstract No. 182).
   Google Scholar
• Hurban P : Toward an integrative systems toxicology.Pharmacogenomics5(8) , 1163–6 (2004).
   Google Scholar

Websites

• National Institute of Environmental Health Sciences (NIEHS): Chemical Effects in Biological Systems (CEBS) knowledgebase. http://cebs.niehs.nih.gov/
   Google Scholar
• US Food and Drugs Administration: National Center for Toxological research – ArrayTrack. www.fda.gov/nctr/science/centers/toxicoinformatics/ArrayTrack/
   Google Scholar
• Microarray Informatics Team: ArrayExpress. www.ebi.ac.uk/arrayexpress/
   Google Scholar
• National Center for Biotechnology Research: Gene Expression Omnibus. www.ncbi.nlm.nih.gov/geo/
   Google Scholar
• Gene Logic Inc. www.genelogic.com
   Google Scholar
• CuraGen Corporation: Predictive Toxicogenomic Screen. www.curagen.com/rnd/pts.asp
   Google Scholar
• Iconix Biosciences, Inc. www.iconixbiosciences.com
   Google Scholar